Kieran O'Kane insider trades: Biodesix (BDSX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kieran reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | BDSX | ↓ Sell | 584 | $10.08 | $6K | Direct | Feb 11, 2026 (1d) |
| Jan 16, 2026 | BDSX | ↓ Sell | 298 | $8.15 | $2K | Direct | Jan 20, 2026 (4d) |
| Nov 10, 2025 | BDSX | ↓ Sell | 25 | $7.62 | $191 | Direct | Nov 13, 2025 (3d) |
| Aug 13, 2025 | BDSX | ↓ Sell | 476 | $0.42 | $198 | Direct | Aug 14, 2025 (1d) |
| May 13, 2025 | BDSX | ↓ Sell | 477 | $0.36 | $170 | Direct | May 13, 2025 (0d) |
| Feb 11, 2025 | BDSX | ↓ Sell | 17,527 | $0.92 | $16K | Direct | Feb 12, 2025 (1d) |
| Nov 12, 2024 | BDSX | ↓ Sell | 462 | $1.40 | $645 | Direct | Nov 13, 2024 (1d) |
| Aug 12, 2024 | BDSX | ↓ Sell | 465 | $1.59 | $741 | Direct | Aug 12, 2024 (0d) |
| May 9, 2024 | BDSX | ↓ Sell | 468 | $1.48 | $692 | Direct | May 10, 2024 (1d) |
| Feb 12, 2024 | BDSX | ↓ Sell | 11,731 | $1.80 | $21K | Direct | Feb 12, 2024 (0d) |
| Nov 10, 2023 | BDSX | ↓ Sell | 469 | $1.25 | $585 | Direct | Nov 13, 2023 (3d) |
| Aug 10, 2023 | BDSX | ↓ Sell | 1,699 | $1.33 | $2K | Direct | Aug 10, 2023 (0d) |
| May 10, 2023 | BDSX | ↓ Sell | 1,697 | $1.57 | $3K | Direct | May 10, 2023 (0d) |
| Feb 9, 2023 | BDSX | ↓ Sell | 1,999 | $1.80 | $4K | Direct | Feb 10, 2023 (1d) |
| Nov 10, 2022 | BDSX | ↓ Sell | 1,705 | $1.03 | $2K | Direct | Nov 10, 2022 (0d) |
| Aug 9, 2022 | BDSX | ↓ Sell | 1,673 | $2.53 | $4K | Direct | Aug 10, 2022 (1d) |
| May 10, 2022 | BDSX | ↓ Sell | 1,583 | $1.83 | $3K | Direct | May 11, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BDSX insiders
Open-market trades in the last 12 months
About Kieran O'Kane's insider trades
Kieran O'Kane is Chief Commercial Officer at Biodesix (BDSX). Since May 10, 2022, Kieran has reported no open-market purchases and 17 sales worth $66K on SEC Form 4. In the last 12 months: 3 sales ($9K).
Their filings also include option exercises (18 filings), grants and awards (12 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BDSX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.